Drug Topics Newsletter

To view this email as a web page, click here.

PHARMACISTS' REPORT

Opinion: Patient-Centered Care and the Heart of Independents

"Community pharmacies have reasons to be optimistic..." writes Jhaveri.

DEA to Slash Opioid Production

Fentanyl, oxymorphone, and hydrocodone face greatest cuts.

FDA Approves First Drug Under Project Orbis

Combination therapy for advance endometrial carcinoma.

More

What's your experience with compounding?

Drug Topics wants to know what you know about compounded formulations! Tell us about your experience with preparing compounded formulations, and your opinion on an oral solution that's easy to reconstitute in the pharmacy setting. Take the survey now.

Bespoke Clinical Services that Independent Pharmacies Can Provide to Patients

Independent Pharmacies: Not Dead Yet

ASHP Release New Guidelines for Perioperative Pharmacists

When Shingles Gets in Your Eyes

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.